Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical liothyronine and insulin for diabetic foot ulcer healing
IRCT20190810044500N20Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of liothyronine, human insulin and alpha in diabetic foot ulcer (DFU) (3 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Percentage of wound closure per week, Time to 50% re-epithelialization and 1 more. Started Sep 2021; status: completed.
02
Drugs
liothyroninehuman insulinalpha
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on IRCT20190810044500N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190810044500N20.